Clinical Nuclear Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 9.6 | Q1 | 96.8% | 0.583 | Q2 | 66.6% |
| 2024 | 9.6 | Q1 | 97.7% | 0.653 | Q2 | 71.3% |
| 2023 | 9.6 | Q1 | 98.0% | 0.571 | Q2 | 69.3% |
| 2022 | 10.6 | Q1 | 98.5% | 0.507 | Q2 | 66.7% |
| 2021 | 10.8 | Q1 | 97.4% | 0.520 | Q2 | 68.4% |
| 2020 | — | — | 0.637 | Q2 | 73.5% | |
| 2019 | — | — | 0.580 | Q2 | 71.7% | |
| 2018 | — | — | 0.850 | Q2 | 80.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1536-0229
ISSN
0363-9762
country
UScoverage
1978-2026